A model to estimate the potential economic benefits of measles eradication for the United States

Vaccine

Volumn 16, Issue 20, 1998, Pages 1917-1922

  Miller, Mark A ^a   Redd, Stephen ^b   Hadler, Stephen ^b   Hinman, Alan ^c  

^a Children's Vaccine Initiative   (Switzerland)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Task Force Child Survival and Devmt   (United States)

Author keywords

Economics; Eradication; Measles

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; GOVERNMENT; HEALTH CARE COST; HUMAN; INCIDENCE; INFECTION CONTROL; MEASLES; MEASLES VACCINATION; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; RESOURCE ALLOCATION; UNITED STATES;

ADOLESCENT; CHILD; COST OF ILLNESS; DISEASE OUTBREAKS; HEALTH POLICY; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INCIDENCE; INTERNATIONAL COOPERATION; MEASLES; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MODELS, ECONOMIC; MUMPS VACCINE; PRIMARY PREVENTION; RUBELLA VACCINE; UNITED STATES; VACCINES, COMBINED;

EID: 0032374320     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00125-X     Document Type: Article

References (39)

1. 1 Sencer, D.J., Dull, H.B. and Langmuir, A.D. Epidemiologic basis for eradication of measles in 1967. Public Health Reports 1967, 82, 253-256.
2. 2 Hinman, A., Brandling-Bennett, A.D. and Nieburg, P.I. The opportunity and obligation to eliminate measles from the United States. JAMA 1979, 242, 1157-1162.
3. 3 Hopkins, D.R., Hinman, A.R., Koplan, J.P. and Lane, J.M. The case for global measles eradication. The Lancet 1982, 00, 1396-1398.
4. 4 Bart, K.J., Orenstein, W.A. and Hinman, A.R. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles. Developments in Biological Standardization 1986, 65, 45-52.
5. 5 Recommendations from a meeting on the feasibility of global measles eradication. MMWR 1996, 45, 891-892.
6. 6 World Health Organization. Meeting on advances in measles eradication: conclusions and recommendations. Weekly Epidemiol Report 1996, 71, 305-309.
7. 7 Centers for Disease Control. Measles prevention. MMWR 1989, 38(Suppl. 9), 1-18.
8. 8 Centers for Disease Control and Prevention. Measles -United States, first 26 weeks 1993, MMWR 1994, 42, 813-816.
9. 9 Centers for Disease Control and Prevention. Measles -United States, 1994. MMWR 1995, 44, 486-494.
10. 10 Centers for Disease Control and Prevention. Measles -United States, 1995. MMWR 1996, 45, 305-307.
11. 11 Centers for Disease Control and Prevention. Measles -United States, 1996. MMWR 1997, 46, 242-246.
12. 12 Centers for Disease Control and Prevention. Measures -United States, 1997. MMWR 1998, 47, 273-276.
13. 13 White, C.C., Koplan, J.P. and Orenstein, W.A. Benefits, risks and costs of immunization for measles, mumps and rubella. American Journal of Public Health 1985, 75, 739-744.
14. 14 Hatziandreu, E., Halpern, M.T., Brown, R.E. and Watson, J. A cost benefit analysis of the measles-mumps-rubella (MMR) vaccine. Report prepared for the Centers for Disease Control and Prevention. Arlington, VA: Battelle. 1994.
15. 15 Robertson, S.E., Markowitz, L.E., Berry, D.A., Dini, E.F. and Orenstein, W.A. A million dollar measles outbreak: epidemiology, risk factors and a selective revaccination strategy. Public Health Reports 1992, 107, 24-31.
16. 16 Pelletier, L.P., Chung, P., Duclos, P., Manga, P., Chung, P. and Scott, J. A benefit-cost analysis of two-dose measles immunization in Canada. Vaccine 1998, 16, 989-996.
17. 17 Pan American Health Organization. Expanded programme on immunization. Accelerated measles strategy. Weekly Epidemiological Record 1994, 69, 229-234.
18. 18 Pan American Health Organization. Expanded programme on immunization (EPI). Measles control/elimination initiatives in the Americas. Weekly Epidemiological Record 1994, 69, 197-200.
19. 19 de Quadros, C., Olive, J.M. and Hersh, B.S. et al. Measles elimination in the Americas. JAMA 1996, 275, 224-229.
20. 20 Pan American Health Organization. Four years without measles! EPI Newsletter 1996, 18(1), 1-3.
21. 21 Pan American Health Organization. Expanded programme on immunization. International importations of measles from the Americas into the United States, 1990-1994. Weekly Epidemiological Record 1995, 70, 164-166.
22. 22 Vitek, C.R., Redd, S.C., Redd, S.B. and Hadler, S.C. Trends in importation of measles to the United States, 1986-1994. JAMA 1997, 277, 1952-1956.
23. 23 Pan American Health Organization. Expanded programme on immunization. Measles elimination by the year 2000 in the Americas. Weekly Epidemiological Record 1995, 70, 113-115.
24. 24 Paunio, M., Virtanen, M., Peltola, H., Cantell, K., Paunio, P., Valle, M., Karanko, V. and Heinonen, O.M. Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps and rubella prevention program in Finland. American Journal of Epidemiology 1991, 133, 1152-1160.
25. 25 Peltola, H., Karanko, V., Kurki, T., Hukkanen, V., Virtanen, M., Penttinen, K., Nissinen, M. and Heinonen, O.P. Rapid effect on endemic measles, mumps and rubella of nationwide vaccination programme in Finland. Lancet 1986, 1, 137-139.
26. 26 Peltola, H., Heinonen, O.P., Valle, M., Paunio, M., Virtanen, M. and Karanko, V. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two-dose vaccination program [see comments]. New England Journal of Medicine 1994, 331, 1397-1402.
27. 27 Public Health Laboratory Service. Information for all doctors. Update of success of measles/rubella immunisation campaign. Health Bulletin 1995, 53, 235-239.
28. 28 Public Health Laboratory Service. Interruption of measles transmission in school children, 1995. Weekly Epidemiological Record 1995, 70, 215-217.
29. 29 Centers for Disease Control and Prevention. Status report on the Childhood Immunization Initiative: national, state and urban area vaccination coverage levels among children aged 19-35 months - United States, 1996. MMWR 1997, 46, 657-664.
30. 30 Centers for Disease Control and Prevention. Report No. 93, US Biological Surveillance, 1987-1990. US Dept of Health and Human Services, Public Health Service, 1991.
31. 31 Miller, M.A., Sutter, R.W., Strebel, P.M. and Hadler, S.C. Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA 1996, 276, 967-971.
32. 32 Schaffer, P. Productivity loss tables. In Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. Eds A.C. Haddix, S.C. Teutsch, P.A. Shaffer and D.O. Dunet. Oxford University Press, New York, 1996, pp. 187-192.
33. 33 Hinman, A.R., Bart, K.J. and Hopkins, D.R. Costs of not eradicating measles. American Journal of Public Health 1985, 75, 713-714.
34. 34 Loras-Duclaux, I., David, L., Peyramond, D., Floret, D., Lachaux, A. and Hermier, M. Epidemiological study and cost evaluation of measles in Lyons hospitals over a 5-year period. In French. Pediatrie 1988, 43, 451-454.
35. 35 Cardenas Ayala, V.M., Ruiz Matus, C., Cabrera Coello, L., Montesano Castellanos, R., Garrido Lozado, M.T., Olvera Castillo, R. and Diaz Ortega, J.L. Estimate of the cost/benefit ratio of measles vaccination. In Spanish. Salud Publica de Mexico 1989, 31, 735-744.
36. 36 Pan American Health Organization. PAHO measles reference laboratory network. Bulletin of the Pan American Health Organization 1995, 29, 276-278.
37. 37 Taylor, C.E. and Cutts, F. Ethical dilemmas in current planning for polio eradication. American Journal of Public Health 1987, 87, 922-925.
38. 38 Sutter, R.W. and Cochi, S.L. Comment: ethical dilemmas in current planning for polio eradication. American Journal of Public Health 1987, 87, 913-916.
39. 39 Centers for Disease Control and Prevention. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization and CDC. MMWR 1997, 46(RR-11), 1-20.